Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
License Agreement
Sort By
Newest First
1 / 1
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04
May 09, 2022
License Agreement
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China
Nuance Pharma
PR-M03-22-08
Mar 21, 2022
License Agreement
Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed
Poolbeg Pharma PLC
PR-M01-22-22
Jan 31, 2022
Licensing
Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases
Corbus
PR-M06-21-009
Jun 07, 2021
Agreement
Hansa Biopharma Announces Exclusive Agreement with Sarepta Therapeutics to Develop Imlifidase as Pre-treatment Ahead of Gene Therapy
Sarepta Therapeutics, Inc
PR-M07-20-NI-004
Jul 03, 2020
Licensing Agreement
Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder
Massachusetts Eye and Ear
PR-M07-20-NI-001
Jul 03, 2020
Licensing
Ionis Licenses Hepatitis B Program to GSK
Ionis Pharmaceuticals, Inc.
PR-M08-19-NI-085
Aug 29, 2019
License Agreement
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
Astellas
PR-M07-19-NI-055
Jul 22, 2019
Licensing
Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Trastuzumab Biosimilar in the Russian Federation
Prestige BioPharma
PR-M07-19-NI-021
Jul 09, 2019
Licensing
argenx Licenses Halozyme Subcutaneous Delivery Tech
Nice Insight
PAO-M02-19-NI-002
Feb 05, 2019
License Agreement
Ablexis Announces Licensing Agreement with Allogene Therapeutics
Ablexis, LLC
PR-M12-18-NI-026
Dec 10, 2018
Agreement
REGENXBIO and Rocket Pharmaceuticals Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector
REGENXBIO
PR-M11-18-NI-108
Nov 30, 2018
Investment
Kaneka has invested in AB-Biotics SA, a Spanish biotech company and concluded a license agreement for production and sales of its probiotics products
Kaneka
PR-M05-18-NI-067
May 17, 2018
1 / 1
